|
|
|
Volumn 16, Issue 1, 1998, Pages 53-59
|
|
Immunological approaches for the treatment of prostate cancer
a
a
NONE
(United States)
|
|
Author keywords
Dendritic cells; Effectors; Gene therapy; Prostate cancer; Targeted therapy; Vaccines
|
|
Indexed keywords
ACID PHOSPHATASE PROSTATE ISOENZYME;
ALKALINE PHOSPHATASE;
ANTIBODY;
ANTISENSE OLIGONUCLEOTIDE;
CARBOHYDRATE ANTIGEN;
CYTOKINE;
DNA;
GAMMA INTERFERON;
GLYCOPROTEIN;
GRANULOCYTE COLONY STIMULATING FACTOR;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
HLA ANTIGEN;
IMMUNOGLOBULIN G;
IMMUNOGLOBULIN M;
IMMUNOLOGICAL ADJUVANT;
INTERCELLULAR ADHESION MOLECULE 1;
INTERFERON;
INTERLEUKIN 2;
KEYHOLE LIMPET HEMOCYANIN;
LIPOSOME;
MAJOR HISTOCOMPATIBILITY ANTIGEN;
MEMBRANE ANTIGEN;
MONOCLONAL ANTIBODY;
MUCIN;
PROSTATE SPECIFIC ANTIGEN;
PROSTATE SPECIFIC MEMBRANE ANTIGEN;
TUMOR NECROSIS FACTOR;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
UVOMORULIN;
VACCINE;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CANCER RECURRENCE;
CLINICAL TRIAL;
ELECTROPORATION;
GENE THERAPY;
GENE TRANSFER;
GENETIC ENGINEERING;
GENETIC TRANSFECTION;
HUMAN;
MALE;
NONHUMAN;
PRIORITY JOURNAL;
PROSTATE CANCER;
QUALITY OF LIFE;
SUICIDE GENE;
CANCER VACCINES;
DENDRITIC CELLS;
GENE THERAPY;
HUMANS;
MALE;
PROSTATE-SPECIFIC ANTIGEN;
PROSTATIC NEOPLASMS;
QUALITY OF LIFE;
RECURRENCE;
|
|
EID: 0031886192
PISSN: 10810943
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (30)
|
|
References (50)
|
